Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | RAC2 | P15153 | 1/20 | 0.32 |
| ▸ | RAC3 | P60763 | 1/20 | 0.32 |
| ▸ | CDC42 | P60953 | 1/20 | 0.32 |
| ▸ | RAC1 | P63000 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
| ▸ | F9 | P00740 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24232937 | 0.97 | ALOX5 (0.35) | ALOX5KDM4EATML3MBTL1RAC2 | |
| SCHEMBL17231991 | 0.97 | ALOX5 (0.36) | ALOX5KDM4EATML3MBTL1RAC2 | |
| SCHEMBL22078193 | 0.95 | ALOX5 (0.34) | ALOX5KDM4EATML3MBTL1LIMK1 | |
| SCHEMBL22078201 | 0.94 | ALOX5 (0.34) | ALOX5KDM4EATML3MBTL1ADORA2A | |
| SCHEMBL24216618 | 0.93 | ALOX5 (0.35) | ALOX5KDM4EATML3MBTL1LIMK1 | |
| SCHEMBL22078284 | 0.93 | ALOX5 (0.34) | ALOX5KDM4EATML3MBTL1ADORA2A | |
| SCHEMBL25928497 | 0.93 | ALOX5 (0.36) | ALOX5KDM4EATML3MBTL1LIMK1 | |
| SCHEMBL25714305 | 0.93 | ALOX5 (0.41) | ALOX5KDM4EATML3MBTL1LIMK1 | |
| SCHEMBL24264572 | 0.92 | ALOX5 (0.35) | ALOX5KDM4EATML3MBTL1RAC2 | |
| SCHEMBL25928433 | 0.92 | ALOX5 (0.37) | ALOX5KDM4EATML3MBTL1LIMK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220056048-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2022-02-24 | — | — | US | disclosed |
| WO-2020116800-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | 주식회사 엘지화학 | 2020-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220056048-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, ARRB1 | ALOX5 1378/4885KDM4E 3925/4885ATM 2133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.